Chemotherapy plus Radiotherapy Compared with Radiotherapy Alone in the Treatment of Locally Advanced, Unresectable, Non-Small-Cell Lung Cancer: A Meta-Analysis

Annals of Internal Medicine

Volumn 125, Issue 9, 1996, Pages 723-729

  Pritchard, Robert S ^a   Anthony, Stephen P ^b  

^a Department of Medicine ^*  (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; META ANALYSIS; MORTALITY; MULTIMODALITY CANCER THERAPY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS;

EID: 0030292602     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-125-9-199611010-00003     Document Type: Article

References (26)

1. Parker S, Tong T, Bolden S, Wingo P. Cancer statistics, 1996. CA Cancer J Clin. 1996;46:5-27.
2. Ginsberg R, Kris M, Armstrong J. Cancer of the lung: non-small cell lung cancer. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. Philadelphia: Lippincott; 1993:673-723.
3. Payne D. Non-small-cell lung cancer: should unresectable stage III patients routinely receive high-dose radiation therapy? J Clin Oncol. 1988;6:552-8.
4. Shepard FA. Future directions in the treatment of non-small cell lung cancer. Semin Oncol. 1994;21(3 Suppl 4):48-62.
5. van Houtte P, Klastersky J, Renaud A, Michael J, Vandermoten G, Nguyen H, et al. Induction chemotherapy with cisplatin, etoposide and vindesine before radiation therapy for nonsmall-cell lung cancer. A randomized study. Antibiot Chemother. 1988;41:131-7.
6. Mattson K, Holsti LR, Holsti P, Jakobsson M, Kajanti M, Liippo K, et al. Inoperable non-small cell lung cancer: radiation with or without chemotherapy. Eur J Cancer Clin Oncol. 1988;24:477-82.
7. Soresi E, Clerici M, Grilli R, Borghini U, Zucali R, Leoni M, et al. A randomized clinical trial comparing radiation therapy v radiation therapy plus cis-dichlorodiammine platinum (II) in the treatment of locally advanced non-small cell lung cancer. Semin Oncol. 1988;15(6 Suppl 7):20-5.
8. Le Chevalier T, Arriagada R, Quoix E, Ruffie P, Martin M, Tarayre M, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst. 1991;83:417-23.
9. Schaake-Koning C, van den Bogaert W, Dalesio O, Festen J, Hoogenhout J, van Houtte P, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med. 1992;326:524-30.
10. Trovo MG, Minatel E, Franchin G, Boccieri MG, Nascimben O, Bolzicco G, et al. Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1992;24:11-5.
11. Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med. 1990;323:940-5.
12. Gregor A, Macbeth FR, Paul J, Cram L, Hansen HH. Radical radiotherapy and chemotherapy in localized inoperable non-small-cell lung cancer: a randomized trial. J Natl Cancer Inst. 1993;85:997-9.
13. Jeremic B, Shibamoto Y, Acimovic L, Djuric L. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer. J Clin Oncol. 1996;13:452-8.
14. Sause WT, Scott C, Taylor S, Johnson D, Livingston R, Komaki R, et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst. 1995;87:198-205.
15. Blanke C, Ansari R, Mantravadi R, Gonin R, Tokars W, Fisher W, et al. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol. J Clin Oncol. 1995;13:1425-9.
16. Trovo MG, Minatel E, Veronesi A: Roncadin M, De Paoli A, Franchin G, et al. Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma. A randomized study. Cancer. 1990;65:400-4.
17. Johnson DH, Einhorn LH, Bartolucci A, Birch R, Omura G, Perez CA, et al. Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann Intern Med. 1990; 113:33-8.
18. Morton RF, Jett JR, McGinnis WL, Earle JD, Therneau TM, Krook JE, et al. Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial. Ann Intern Med. 1991;115:681-6.
19. Grilli R, Oxman AD, Julian JA. Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough? J Clin Oncol. 1993;11:1866-72.
20. Rothman KJ. Modern Epidemiology Boston: Little, Brown; 1986.
21. Greenland S, Robbins JM. Estimation of a common effect parameter from sparse follow-up data. Biometrics. 1985;41:55-68.
22. Crino L, Meacci M, Corgna E, Maranzano E, Checcaglini F, Darwish S, et al. Long term results in locally advanced inoperable non small cell lung cancer (NSCLC): a randomized trial of induction chemotherapy (CT) plus radiotherapy (RT) vs radiation alone [Abstract]. Lung Cancer. 1991;75:161.
23. Mira J, Miller T, Crowley J. Chest irradiation (RT) vs chest RT and chemotherapy ± prophylactic brain RT in localized non-small-cell lung cancer. A Southwest Oncology Group randomized study. Int J Radiat Oncol Biol Phys. 1990;19(Suppl):145.
24. Wolf M, Hans K, Hassler R, von Bultzingslowen F, Goerg R, Klaasen HA, et al. Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer. Semin Oncol. 1994;21(3 Suppl 4):42-7.
25. Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA. 1990;263:1385-9.
26. Stewart LA, Parmar MK. Meta-analysis of the literature or of individual patient data: is there a difference? Lancet. 1993;341:418-22.